[How to advance antihypertensive therapy].
D000328:Adult; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000959:Antihypertensive Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000494:pharmacology; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D011453:Prostaglandins / Q000494:pharmacology; D013148:Spironolactone / Q000494:pharmacology; D013997:Time Factors; D000092502:Renin Inhibitors
D000804:Angiotensin II; D000959:Antihypertensive Agents; D002257:Carbonic Anhydrase Inhibitors; D003000:Clonidine; D008750:Methyldopa; D000451:Mineralocorticoid Receptor Antagonists; D011453:Prostaglandins; D013148:Spironolactone; D000092502:Renin Inhibitors
Comment faire progresser la thérapeutique antihypertensive.